In news: In another two to two-and-a-half months, Bharat Biotech is going to have significant data on its intranasal COVID-19 vaccine whose clinical trials are under way.
New vaccine being developed by Hyderabad based Bharat Biotech is BBV154 – A novel adenovirus vectored, intranasal vaccine for COVID-19
Intranasal vaccine is a vaccine administered to a person via thenose and does not require a needle.
